Girard Partners Ltd. Baxter International Inc Transaction History

Girard Partners Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 11, 2019	SELL	$61.45 - $77.8 $117,062 - $148,209	-1,905 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$70.71 - $77.75 $238,646 - $262,406	-3,375 Reduced 63.92%	1,905 $146,000
Q2 2018 Aug 07, 2018	BUY	$63.43 - $75.41 $334,910 - $398,164	5,280 New	5,280 $390,000
Q1 2018 Apr 18, 2018	SELL	$62.56 - $72.26 $444,176 - $513,046	-7,100 Closed	0 $0
Q4 2017 Feb 07, 2018	SELL	$61.45 - $66.05 $55,182 - $59,312	-898 Reduced 11.23%	7,100 $459,000
Q3 2017 Nov 08, 2017	SELL	$59.5 - $64.61 $10,769 - $11,694	-181 Reduced 2.21%	7,998 $502,000
Q2 2017 Aug 08, 2017	BUY	N/A	8,179	8,179 $495,000

981

446M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $19.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

Stay updated on Girard Partners Ltd. with notifications on news.